| Old Articles: <Older 2531-2540 Newer> |
|---|
 |
The Motley Fool
June 30, 2004
Roger Nusbaum |
Freddie's Follies What's next for the mortgage behemoth, Freddie Mac?   |
The Motley Fool
June 30, 2004
Bill Mann |
Thoratec's Palpitations Are the company's heart devices unwanted, or just being adopted more slowly than expected? Several Wall Street analysts responded by slashing their ratings on the firm. |
The Motley Fool
June 30, 2004
Phil Wohl |
General Mills Needs Its Wheaties Fourth-quarter earnings are as expected, but the company warns for fiscal 2005. |
The Motley Fool
June 30, 2004
Seth Jayson |
Kmart Lightens Up Again This year's turnaround darling sells a few more locations to an old adversary. What this means for shareholders is tougher to determine. |
The Motley Fool
June 30, 2004
Rich Smith |
7 Steps to Finding Gems How to find a company's investment potential. |
The Motley Fool
June 30, 2004
Steven Mallas |
Campbell's Cold Earnings Soup The company scales back the growth rate it announced three years ago. That's not a good sign. |
The Motley Fool
June 30, 2004
Rich Smith |
Siebel Spills Secrets Inaugural Regulation Fair Disclosure (Reg FD) violator Siebel Systems, provider of customer relationship management (CRM) software, is in trouble with the SEC yet again. |
The Motley Fool
June 30, 2004
Alyce Lomax |
A Monster Drug for Lilly? The drug giant files a new drug application (NDA) for its experimental new drug for diabetics. |
The Motley Fool
June 30, 2004
Mike Cianciolo |
1-800-Flowers.com Droops The online flower and gift retailer projects lower-than-anticipated sales for the fourth quarter. |
The Motley Fool
June 30, 2004
Seth Jayson |
Euro Tech's Ripe for Scam A tiny Hong Kong company produces bland results, and speculators jump on for the ride. |
| <Older 2531-2540 Newer> Return to current articles. |
